当前位置:首页 - 行情中心 - 佛慈制药(002644) - 财务分析

佛慈制药

(002644)

  

流通市值:46.78亿  总市值:46.78亿
流通股本:5.11亿   总股本:5.11亿

佛慈制药(002644)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.40亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益179396.30万元,未分配利润79995.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产247158.50万元,负债67762.20万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入708,531,496.45498,880,666.79274,329,503.971,163,134,313.96
营业总成本651,587,799.98449,707,132.77245,785,793.531,079,170,441.49
营业利润46,318,676.842,258,111.8422,999,318.6483,274,839.55
利润总额45,671,825.0741,791,647.0622,602,706.181,641,772.72
净利润40,448,681.7937,063,854.9418,641,576.1768,121,997.68
其他综合收益487,793.63496,374.73--241,981.88
综合收益总额40,936,475.4237,560,229.6718,641,576.1767,880,015.8
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,226,581,252.211,217,278,140.631,252,844,935.251,238,869,322.84
非流动资产合计1,245,003,724.11,267,142,953.891,274,657,410.661,289,232,891.52
资产总计2,471,584,976.312,484,421,094.522,527,502,345.912,528,102,214.36
流动负债合计409,206,882.67419,663,769.63462,403,589.12467,687,510.56
非流动负债合计268,415,106.51274,086,870.73278,027,246.13291,984,769.31
负债合计677,621,989.18693,750,640.36740,430,835.25759,672,279.87
归属于母公司股东权益合计1,769,241,841.61,766,402,316.171,763,758,032.041,745,370,807.77
股东权益合计1,793,962,987.131,790,670,454.161,787,071,510.661,768,429,934.49
负债和股东权益合计2,471,584,976.312,484,421,094.522,527,502,345.912,528,102,214.36
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计556,915,313.5410,834,644.82179,828,915.87977,164,304.36
经营活动现金流出小计573,094,864.09417,599,155.15195,903,367.04911,450,004.5
经营活动产生的现金流量净额-16,179,550.59-6,764,510.33-16,074,451.1765,714,299.86
投资活动现金流入小计11,504.4211,504.42-9,773,328.77
投资活动现金流出小计8,789,743.387,559,621.192,090,979.343,928,615.13
投资活动产生的现金流量净额-8,778,238.96-7,548,116.77-2,090,979.3-34,155,286.36
筹资活动现金流入小计10,050,000--26,160,000
筹资活动现金流出小计39,510,365.5429,358,876.6713,886,666.6751,161,366.66
筹资活动产生的现金流量净额-29,460,365.54-29,358,876.67-13,886,666.67-25,001,366.66
汇率变动对现金及现金等价物的影响---674,477.75
现金及现金等价物净增加额-54,418,155.09-43,671,503.77-32,052,097.147,232,124.59
期末现金及现金等价物余额351,622,449.61362,369,100.93364,264,596.44396,316,693.58
最新报告期:2024-08-28
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
长城证券刘鹏,蔡航,袁紫馨0.140.210.262024-08-28
TOP↑